Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3481)
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,394
Price
$41.92
Total Value
$100.35K
Shares Held After
447,133
% of Holdings
0.5%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
65,832
Price
$38.42
Total Value
$2.53M
Shares Held After
460,828
% of Holdings
12.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
5,715
Price
$80.09
Total Value
$457.71K
Shares Held After
33,243
% of Holdings
14.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Bjork Elisabeth — Director
Shares
10,000
Price
$3.44
Total Value
$34.40K
Shares Held After
50,000
% of Holdings
20.0%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Anzalone Christopher Richard — Director
Shares
7,416
Price
$65.88
Total Value
$488.57K
Shares Held After
3,798,510
% of Holdings
0.2%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$7.43
Total Value
$123.78K
Shares Held After
1,308,103
% of Holdings
1.3%
Janux Therapeutics, Inc. (JANX)
Dobek Maria — Vice President, Accounting
Shares
1,462
Price
$13.73
Total Value
$20.07K
Shares Held After
15,373
% of Holdings
8.7%
Janux Therapeutics, Inc. (JANX)
McIver Zachariah — Chief Medical Officer
Shares
2,714
Price
$13.73
Total Value
$37.26K
Shares Held After
23,286
% of Holdings
10.4%
Janux Therapeutics, Inc. (JANX)
Winter Charles M. — Chief Technical Officer
Shares
2,401
Price
$13.73
Total Value
$32.97K
Shares Held After
77,721
% of Holdings
3.0%
Janux Therapeutics, Inc. (JANX)
Campbell David Alan — Director
Shares
8,072
Price
$13.73
Total Value
$110.83K
Shares Held After
284,982
% of Holdings
2.8%
Janux Therapeutics, Inc. (JANX)
DiRaimondo Thomas — Chief Scientific Officer
Shares
2,505
Price
$13.73
Total Value
$34.39K
Shares Held After
124,425
% of Holdings
2.0%
Janux Therapeutics, Inc. (JANX)
Meyer Andrew Hollman — Chief Business Officer
Shares
1,879
Price
$13.73
Total Value
$25.80K
Shares Held After
83,095
% of Holdings
2.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
913
Price
$62.09
Total Value
$56.69K
Shares Held After
50,440
% of Holdings
1.8%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
4,000
Price
$28.00
Total Value
$112.00K
Shares Held After
61,740
% of Holdings
6.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
2,840
Price
$30.05
Total Value
$85.34K
Shares Held After
296,991
% of Holdings
0.9%
Beam Therapeutics Inc. (BEAM)
Emany Sravan Kumar — Chief Financial Officer
Shares
6,294
Price
$27.10
Total Value
$170.57K
Shares Held After
73,706
% of Holdings
7.9%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
8,125
Price
$4.07
Total Value
$33.09K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
6,567
Price
$30.05
Total Value
$197.34K
Shares Held After
404,075
% of Holdings
1.6%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
1,254
Price
$27.10
Total Value
$33.98K
Shares Held After
115,667
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
6,014
Price
$78.52
Total Value
$472.21K
Shares Held After
663,077
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
23,986
Price
$77.95
Total Value
$1.87M
Shares Held After
669,091
% of Holdings
3.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
22,497
Price
$41.99
Total Value
$944.74K
Shares Held After
443,739
% of Holdings
5.1%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
1,018,995
Price
$21.71
Total Value
$22.12M
Shares Held After
20,267,429
% of Holdings
4.8%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
10,787
Price
$17.43
Total Value
$188.04K
Shares Held After
52,391
% of Holdings
17.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
24,962
Price
$0.62
Total Value
$15.48K
Shares Held After
2,490,865
% of Holdings
1.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
1,156
Price
$29.39
Total Value
$33.97K
Shares Held After
96,610
% of Holdings
1.2%
Axsome Therapeutics, Inc. (AXSM)
Saad Mark E — Director
Shares
31,346
Price
$165.18
Total Value
$5.18M
Shares Held After
10,002
% of Holdings
75.8%
Axsome Therapeutics, Inc. (AXSM)
Saad Mark E — Director
Shares
6,231
Price
$165.18
Total Value
$1.03M
Shares Held After
10,002
% of Holdings
38.4%
Zentalis Pharmaceuticals, Inc. (ZNTL)
WALTERS GROUP — 10% Owner
Shares
6,459,973
Price
$1.20
Total Value
$7.75M
Shares Held After
13,509,973
% of Holdings
47.8%
Eyenovia, Inc. (EYEN)
Knox David R. — Chief Financial Officer
Shares
27,950
Price
$3.59
Total Value
$100.34K
Shares Held After
327,950
% of Holdings
8.5%
RenovoRx, Inc. (RNXT)
Agah Ramtin — Director
Shares
9,795
Price
$0.86
Total Value
$8.42K
Shares Held After
788,460
% of Holdings
1.2%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
4,300
Price
$21.36
Total Value
$91.85K
Shares Held After
5,599,402
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
541
Price
$28.81
Total Value
$15.59K
Shares Held After
97,766
% of Holdings
0.6%
Viridian Therapeutics, Inc.\DE (VRDN)
Tousignant Jennifer — Chief Legal Officer
Shares
2,272
Price
$31.16
Total Value
$70.80K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
13,095
Price
$5.81
Total Value
$76.08K
Shares Held After
770,495
% of Holdings
1.7%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
5,000
Price
$1.03
Total Value
$5.15K
Shares Held After
291,421
% of Holdings
1.7%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
50,000
Price
$0.95
Total Value
$47.27K
Shares Held After
1,838,551
% of Holdings
2.7%
Arcus Biosciences, Inc. (RCUS)
Goeltz II Robert C. — Chief Financial Officer
Shares
6,552
Price
$23.38
Total Value
$153.19K
Shares Held After
67,924
% of Holdings
8.8%
Vaxcyte, Inc. (PCVX)
Dhaliwal Harpreet S. — Chief Technical Ops Officer
Shares
9,743
Price
$46.69
Total Value
$454.89K
Shares Held After
23,928
% of Holdings
28.9%
Showing 3201–3250 of 3481 transactions (page 65 of 70)